Clinical Trial Update: A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalation and expansion study of the radiopharmaceutical [177Lu]Lu-SN201 for advanced cancer is currently in Phase 1/Phase 2 and actively recruiting. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• [177Lu]Lu-SN201

Snippet

Sponsor: Spago Nanomedical AB | Conditions: Solid Tumor, Metastatic Cancer | Phase 1, Phase 2 | Status: RECRUITING